UCB, Inc.
UCB, Inc.
1950 Lake Park Drive
Smyrna, Georgia 30080
Phone: (770) 970-7500Website: https://www.ucb-usa.com/Careers: careers.ucb.comPatient Assistance Program: www.ucb-usa.com/Patients/Patients
Latest news
- UCB Announces U.S. FDA Acceptance of New Drug Application and EMA MAA Validation for Zilucoplan for the Treatment of Generalized Myasthenia Gravis in Adult Patients
14 November 2022 - Update on U.S. FDA Review of Biologics License Application (BLA) for Bimekizumab - Complete Response Letter
13 May 2022 - UCB Announces Positive Data in Myasthenia Gravis with Zilucoplan Phase 3 Study Results
4 February 2022 - UCB Presents Number Needed to Treat Analysis for Bimekizumab in Moderate to Severe Plaque Psoriasis at AMCP Nexus
22 October 2021 - Update on U.S. FDA Review of Biologics License Application (BLA) for Bimekizumab
16 October 2021 - New Bimekizumab Two-Year Data in Moderate to Severe Plaque Psoriasis Presented at the 30th European Academy of Dermatology and Venereology Congress
29 September 2021 - UCB Announces Briviact (brivaracetam) Now FDA-Approved to Treat Partial-Onset Seizures in Pediatric Patients One Month of Age and Older
30 August 2021 - New Two-Year Data Showed Bimekizumab Maintained High Levels of Skin Clearance in Patients with Moderate to Severe Plaque Psoriasis
7 August 2021 - UCB Announces PDUFA Date for Bimekizumab
28 April 2021 - The New England Journal of Medicine Publishes Results from Two Bimekizumab Phase 3 Studies in Moderate to Severe Plaque Psoriasis
23 April 2021
Drugs Associated with UCB, Inc.
UCB, Inc. manufactures, markets and/or distributes more than 9 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Briviact
Generic name: brivaracetam Drug class: pyrrolidine anticonvulsants |
42 reviews | 6.0 / 10 |
|
Cimzia
Generic name: certolizumab Drug class: TNF alfa inhibitors |
70 reviews | 6.5 / 10 |
|
Keppra
Generic name: levetiracetam Drug class: pyrrolidine anticonvulsants |
270 reviews | 5.6 / 10 |
|
Keppra XR
Generic name: levetiracetam Drug class: pyrrolidine anticonvulsants |
16 reviews | 7.1 / 10 |
|
Nayzilam
Generic name: midazolam Drug class: benzodiazepines |
||
|
Neupro
Generic name: rotigotine Drug class: dopaminergic antiparkinsonism agents |
59 reviews | 7.5 / 10 |
|
Tussionex Pennkinetic
Generic name: chlorpheniramine/hydrocodone Drug class: upper respiratory combinations |
98 reviews | 9.2 / 10 |
|
Vimpat
Generic name: lacosamide Drug class: miscellaneous anticonvulsants |
141 reviews | 6.7 / 10 |
|
Zaroxolyn
Generic name: metolazone Drug class: thiazide diuretics |
3 reviews | 8.0 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
Discontinued Drugs
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Lortab
Generic name: acetaminophen/hydrocodone Drug class: narcotic analgesic combinations |
143 reviews | 8.0 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||
